FDA Drug Application (202671) for IBANDRONATE SODIUM by MYLAN LABS LTD

Back to FDA Applications sponsored by MYLAN LABS LTD

Application Number202671
Product Number001
FormINJECTABLE;INTRAVENOUS
DosageEQ 3MG BASE/3ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameIBANDRONATE SODIUM
Active IngredientIBANDRONATE SODIUM

Active IngredientCount
List of drugs with Active Ingredient IBANDRONATE SODIUM2


Back to FDA Applications sponsored by MYLAN LABS LTD